Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w.
about
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on.Thrombotic thrombocytopenic purpura associated with abacavir in a patient with HIV infection.Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.Current treatment options for primary immune thrombocytopenia.Therapeutic options for immune-mediated thrombocytopenia.Risk and prognosis of adult primary immune thrombocytopenia.Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions.Influence of Intravenous Immunoglobulin Treatment on Thrombopoiesis.Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review.Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.Clinical Practice Updates in the Management Of Immune Thrombocytopenia.An idiopathic thrombocytopenic purpura with polyneuropathy.TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.Current and evolving treatment strategies in adult immune thrombocytopenia
P2860
Q31039951-169B6E35-1821-487F-A143-6AA231C5AACBQ33359740-55E670B8-0702-4735-A3BC-7F6C2AF2C907Q33359746-55A1CAE9-46E8-463A-AAC6-06836EFA2DFEQ33383108-C80A96AD-DCE2-4007-A5DD-29A216F3324CQ33392868-62A76843-B40D-4AD4-8DEC-DBD724C5C48DQ33394149-713E8BCD-8AE0-4A20-9442-506C6EB4F6F5Q33399601-208AA757-3772-4CBC-B97B-A6F18D9D7B29Q33400566-915D578A-A8CD-4C6A-892D-F3BEF3C8C96EQ33402387-0F6098F2-5FAC-4B7C-B0E6-AF42E269BDB9Q33402625-B90D10D1-F86F-4293-95E6-FF456F3390E9Q33426166-0810EA54-E6D4-47B7-8C9A-D194B2B66F46Q33427260-0D3641E2-FE22-448B-8574-715DDBDB0744Q33436047-46BC86A0-030E-47C0-A981-7564DF11C046Q33443173-4ECE3936-872F-4AF5-9337-9741DCD99A2DQ38842992-3ECBD622-B5BD-4D63-9156-382326D672E2Q47161464-41A1A7AA-A0EA-44F7-805C-AB3EFED904D5Q53060073-3EABB36B-76D4-4746-AE9F-42F98D4FB2FCQ54988723-77AFBE47-C588-46E4-AFA6-6119BC10EE6FQ58775920-06CBBABE-4123-4ACE-956B-CFFC45C8F90F
P2860
Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@ast
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@en
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@nl
type
label
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@ast
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@en
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@nl
prefLabel
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@ast
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@en
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@nl
P2093
P2860
P1476
Intravenous immunoglobulin for ...... comparing 0.5 and 1 g/kg b.w.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.1999.01766.X
P407
P577
1999-12-01T00:00:00Z